Page last updated: 2024-09-03
t 593 and bucladesine
t 593 has been researched along with bucladesine in 1 studies
Compound Research Comparison
| Studies (t 593) | Trials (t 593) | Recent Studies (post-2010) (t 593) | Studies (bucladesine) | Trials (bucladesine) | Recent Studies (post-2010) (bucladesine) |
|---|---|---|---|---|---|
| 14 | 0 | 1 | 9,775 | 13 | 210 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Arai, H; Inoie, M; Marubuchi, S | 1 |
Other Studies
1 other study(ies) available for t 593 and bucladesine
| Article | Year |
|---|---|
Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells.
Topics: Aminopyrine; Animals; Anti-Ulcer Agents; Bucladesine; Carbachol; Carbon Radioisotopes; Cholinergic Agonists; Dogs; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Mucosa; Guanidines; Histamine; Histamine H2 Antagonists; Omeprazole; Pentagastrin; Pirenzepine; Ranitidine; Sulfones | 1998 |